• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Strategies on the application of stem cells based therapies for the treatment of optic neuropathies.

作者信息

Behtaj Sanaz, Rybachuk Maksym

机构信息

School of Engineering and Built Environment, Griffith University, Parklands Drive, Southport, Queensland, Australia; Department of Cellular Biotechnology, Cell Science Research Centre, Royan Institute for Biotechnology, Isfahan, Iran; Queensland Micro- and Nanotechnology Centre, Griffith University, Nathan, Queensland, Australia.

Queensland Micro- and Nanotechnology Centre; School of Engineering and Built Environment, Griffith University, Nathan, Queensland, Australia.

出版信息

Neural Regen Res. 2021 Jun;16(6):1190-1191. doi: 10.4103/1673-5374.300343.

DOI:10.4103/1673-5374.300343
PMID:33269770
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8224130/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c3e/8224130/2479b8a8ef3e/NRR-16-1190-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c3e/8224130/2479b8a8ef3e/NRR-16-1190-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4c3e/8224130/2479b8a8ef3e/NRR-16-1190-g001.jpg

相似文献

1
Strategies on the application of stem cells based therapies for the treatment of optic neuropathies.基于干细胞疗法治疗视神经病变的应用策略。
Neural Regen Res. 2021 Jun;16(6):1190-1191. doi: 10.4103/1673-5374.300343.
2
The use of induced pluripotent stem cells for studying and treating optic neuropathies.诱导多能干细胞在视神经病变研究与治疗中的应用。
Curr Opin Organ Transplant. 2016 Oct;21(5):484-9. doi: 10.1097/MOT.0000000000000348.
3
Emerging Mitochondrial Therapeutic Targets in Optic Neuropathies.视神经病变中的新兴线粒体治疗靶点。
Pharmacol Ther. 2016 Sep;165:132-52. doi: 10.1016/j.pharmthera.2016.06.004. Epub 2016 Jun 8.
4
Pluripotent Stem Cell-Based Approaches to Explore and Treat Optic Neuropathies.基于多能干细胞的视神经病变探索与治疗方法。
Front Neurosci. 2018 Sep 20;12:651. doi: 10.3389/fnins.2018.00651. eCollection 2018.
5
New therapies for optic neuropathies: development in experimental models.视神经病变的新疗法：实验模型中的进展
Curr Opin Ophthalmol. 2000 Dec;11(6):421-9. doi: 10.1097/00055735-200012000-00007.
6
Advances in the Differentiation of Retinal Ganglion Cells from Human Pluripotent Stem Cells.人多能干细胞来源视网膜神经节细胞的分化研究进展。
Adv Exp Med Biol. 2019;1186:121-140. doi: 10.1007/978-3-030-28471-8_5.
7
Ischemic optic neuropathies.缺血性视神经病变
Curr Opin Neurol. 2004 Feb;17(1):27-35. doi: 10.1097/00019052-200402000-00006.
8
Therapeutic Strategies for Attenuation of Retinal Ganglion Cell Injury in Optic Neuropathies: Concepts in Translational Research and Therapeutic Implications.视神经病变中视网膜神经节细胞损伤的治疗策略：转化研究的概念和治疗意义。
Biomed Res Int. 2019 Nov 11;2019:8397521. doi: 10.1155/2019/8397521. eCollection 2019.
9
Metabolic optic neuropathies.代谢性视神经病变
Semin Ophthalmol. 2002 Mar;17(1):29-32. doi: 10.1076/soph.17.1.29.10290.
10
Diagnosis and clinical features of common optic neuropathies.常见视神经病变的诊断和临床特征。
Lancet Neurol. 2016 Dec;15(13):1355-1367. doi: 10.1016/S1474-4422(16)30237-X.

引用本文的文献

1
Mesenchymal stem cells for repairing glaucomatous optic nerve.用于修复青光眼性视神经的间充质干细胞
Int J Ophthalmol. 2024 Apr 18;17(4):748-760. doi: 10.18240/ijo.2024.04.20. eCollection 2024.
2
Advances in Electrospun Nerve Guidance Conduits for Engineering Neural Regeneration.用于神经再生工程的电纺神经导向导管的研究进展。
Pharmaceutics. 2022 Jan 18;14(2):219. doi: 10.3390/pharmaceutics14020219.
3
Neuron-fibrous scaffold interfaces in the peripheral nervous system: a perspective on the structural requirements.外周神经系统中的神经元-纤维支架界面：结构要求的观点

本文引用的文献

1
Retinal Tissue Bioengineering, Materials and Methods for the Treatment of Glaucoma.视网膜组织工程学，青光眼治疗的材料和方法。
Tissue Eng Regen Med. 2020 Jun;17(3):253-269. doi: 10.1007/s13770-020-00254-8. Epub 2020 May 10.
2
Neuroprotective Strategies for Retinal Ganglion Cell Degeneration: Current Status and Challenges Ahead.神经保护策略治疗视网膜神经节细胞变性：现状与挑战。
Int J Mol Sci. 2020 Mar 25;21(7):2262. doi: 10.3390/ijms21072262.
3
Therapeutic Strategies for Attenuation of Retinal Ganglion Cell Injury in Optic Neuropathies: Concepts in Translational Research and Therapeutic Implications.
Neural Regen Res. 2022 Sep;17(9):1893-1897. doi: 10.4103/1673-5374.329003.
视神经病变中视网膜神经节细胞损伤的治疗策略：转化研究的概念和治疗意义。
Biomed Res Int. 2019 Nov 11;2019:8397521. doi: 10.1155/2019/8397521. eCollection 2019.
4
The use of mesenchymal stem cells for the treatment of progressive retinal diseases: a review.间充质干细胞在进行性视网膜疾病治疗中的应用：综述。
Regen Med. 2019 May;14(4):321-329. doi: 10.2217/rme-2019-0022. Epub 2019 Apr 12.
5
Retinal Ganglion Cell Replacement: Current Status and Challenges Ahead.视网膜神经节细胞替代：现状与挑战
Dev Dyn. 2019 Jan;248(1):118-128. doi: 10.1002/dvdy.24672. Epub 2018 Oct 11.
6
Neuroprotection in glaucoma: recent advances and clinical translation.青光眼的神经保护：最新进展及临床转化。
Clin Exp Ophthalmol. 2019 Jan;47(1):88-105. doi: 10.1111/ceo.13336. Epub 2018 Jul 1.
7
Retinal ganglion cell neuroprotection by growth factors and exosomes: lessons from mesenchymal stem cells.生长因子和外泌体对视网膜神经节细胞的神经保护作用：来自间充质干细胞的经验教训
Neural Regen Res. 2018 Feb;13(2):228-229. doi: 10.4103/1673-5374.226392.
8
Neuroprotective Effects of Human Mesenchymal Stem Cells and Platelet-Derived Growth Factor on Human Retinal Ganglion Cells.人骨髓间充质干细胞和血小板衍生生长因子对人视网膜神经节细胞的神经保护作用。
Stem Cells. 2018 Jan;36(1):65-78. doi: 10.1002/stem.2722. Epub 2017 Oct 31.
9
The promise of stem cell-based therapeutics in ophthalmology.眼科中基于干细胞疗法的前景。
Neural Regen Res. 2017 Feb;12(2):173-180. doi: 10.4103/1673-5374.200793.
10
Neuroprotective therapies in glaucoma: II. Genetic nanotechnology tools.青光眼的神经保护疗法：II. 基因纳米技术工具
Front Neurosci. 2015 Oct 14;9:355. doi: 10.3389/fnins.2015.00355. eCollection 2015.